You are here

  • Home
  • Archive
  • Volume 26, Issue 1
  • Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial

Article metrics

Article menu
Download PDFPDF
Gestational Trophoblastic Neoplasia
Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial

 

Online download statistics by month:

Online download statistics by month: January 2019 to October 2024

AbstractFullPdf
Jan 2019800
Feb 20191800
Mar 20192600
Apr 20191400
May 20193701
Jun 20192600
Jul 20192500
Aug 20192001
Sep 20192600
Oct 20192200
Nov 20192200
Dec 20191600
Jan 20202900
Feb 20203800
Mar 20203300
Apr 20202400
May 20202401
Jun 20202600
Jul 20203600
Aug 20201200
Sep 20202200
Oct 2020800
Nov 20201701
Dec 2020400
Jan 20213203
Feb 20211002
Mar 20211400
Apr 2021600
May 2021600
Aug 2021002
Oct 20211200
Nov 20211800
Dec 20211800
Jan 20221800
Feb 2022600
Mar 20221700
Apr 20221200
May 20224200
Jun 20224201
Jul 20222700
Aug 20225301
Sep 20223400
Oct 20223900
Nov 20223600
Dec 20222200
Jan 2023400
Feb 20237000
Mar 2023801
Apr 20234800
May 20234001
Jun 2023400
Jul 2023800
Aug 20231800
Sep 2023800
Oct 20231000
Nov 20231900
Dec 20233200
Jan 20242600
Feb 20242200
Mar 20242601
Apr 20243702
May 20242800
Jun 20243000
Jul 20245400
Aug 20242400
Sep 2024400
Oct 2024600
Total1523018